Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Lifestyle
Jessica Burrell

An expert explores the hidden impact of GLP-1s

There’s a debate going on about which will change the world more, AI or GLP-1s (the weight loss medication commonly known under brand names like Ozempic and Mounjaro). Julie Rice positions herself pretty firmly in the latter camp.

Rice was the co-founder of SoulCycle and Peoplehood, but has left active roles in both and is now chief experience officer at Weight Watchers, the weight loss community that emerged from bankruptcy in 2025. The 62-year-old company has now expanded into support in new areas like the menopause, as well as GLP-1 prescription and support, offering ‘wraparound care’ that Rice considers essential.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.